Your browser doesn't support javascript.
loading
Release of miR-29 Target Laminin C2 Improves Skin Repair.
Robinson, Connor J; Thiagarajan, Lalitha; Maynard, Rebecca; Aruketty, Maneesha; Herrera, Jeremy; Dingle, Lewis; Reid, Adam; Wong, Jason; Cao, Heng; Dooley, James; Liston, Adrian; Müllhaupt, Daniela; Hiebert, Paul; Hiebert, Hayley; Kurinna, Svitlana.
Afiliação
  • Robinson CJ; Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Thiagarajan L; Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Maynard R; Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Aruketty M; Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Herrera J; Blond-McIndoe Laboratory, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Dingle L; Blond-McIndoe Laboratory, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Reid A; Blond-McIndoe Laboratory, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Wong J; Blond-McIndoe Laboratory, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Cao H; Division of Pharmacy and Optometry, School of Health Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Dooley J; Center for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium; Department of Microbiology and Immunology, Katholieke Universiteit-University of Leuven, Leuven, Belgium; Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, United
  • Liston A; Center for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), Leuven, Belgium; Department of Microbiology and Immunology, Katholieke Universiteit-University of Leuven, Leuven, Belgium; Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge, United
  • Müllhaupt D; Department of Biology, Institute of Molecular Health Sciences, Eidgenössische Technische Hochschule Zürich (ETH) Zurich, Zurich, Switzerland.
  • Hiebert P; Department of Biology, Institute of Molecular Health Sciences, Eidgenössische Technische Hochschule Zürich (ETH) Zurich, Zurich, Switzerland.
  • Hiebert H; Department of Biology, Institute of Molecular Health Sciences, Eidgenössische Technische Hochschule Zürich (ETH) Zurich, Zurich, Switzerland.
  • Kurinna S; Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom. Electronic address: svitlana.kurinna@manchester.ac.uk.
Am J Pathol ; 194(2): 195-208, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37981221
ABSTRACT
miRNAs are small noncoding RNAs that regulate mRNA targets in a cell-specific manner. miR-29 is expressed in murine and human skin, where it may regulate functions in skin repair. Cutaneous wound healing model in miR-29a/b1 gene knockout mice was used to identify miR-29 targets in the wound matrix, where angiogenesis and maturation of provisional granulation tissue was enhanced in response to genetic deletion of miR-29. Consistently, antisense-mediated inhibition of miR-29 promoted angiogenesis in vitro by autocrine and paracrine mechanisms. These processes are likely mediated by miR-29 target mRNAs released upon removal of miR-29 to improve cell-matrix adhesion. One of these, laminin (Lam)-c2 (also known as laminin γ2), was strongly up-regulated during skin repair in the wound matrix of knockout mice. Unexpectedly, Lamc2 was deposited in the basal membrane of endothelial cells in blood vessels forming in the granulation tissue of knockout mice. New blood vessels showed punctate interactions between Lamc2 and integrin α6 (Itga6) along the length of the proto-vessels, suggesting that greater levels of Lamc2 may contribute to the adhesion of endothelial cells, thus assisting angiogenesis within the wound. These findings may be of translational relevance, as LAMC2 was deposited at the leading edge in human wounds, where it formed a basal membrane for endothelial cells and assisted neovascularization. These results suggest a link between LAMC2, improved angiogenesis, and re-epithelialization.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Laminina / MicroRNAs Limite: Animals / Humans Idioma: En Revista: Am J Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Laminina / MicroRNAs Limite: Animals / Humans Idioma: En Revista: Am J Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido